BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10405366)

  • 1. Quantification of endogenous viral polymerase, 3D(pol), in preparations of Mengo and encephalomyocarditis viruses.
    Frolov VG; Duque H; Palmenberg AC
    Virology; 1999 Jul; 260(1):148-55. PubMed ID: 10405366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg.
    Paul AV; Mugavero J; Yin J; Hobson S; Schultz S; van Boom JH; Wimmer E
    Virology; 2000 Jun; 272(1):72-84. PubMed ID: 10873750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalomyocarditis and Mengo viruses productively infect murine T-lymphocyte cell lines but not fresh ex vivo derived T lymphocytes.
    Neal ZC; Harms JS; Hill MR; Splitter GA
    Viral Immunol; 2002; 15(1):155-63. PubMed ID: 11952137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunogenic and pathogenic potential of short poly(C) tract Mengo viruses.
    Osorio JE; Martin LR; Palmenberg AC
    Virology; 1996 Sep; 223(2):344-50. PubMed ID: 8806569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of "authentic" poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease-mediated cleavage in Escherichia coli.
    Gohara DW; Ha CS; Kumar S; Ghosh B; Arnold JJ; Wisniewski TJ; Cameron CE
    Protein Expr Purif; 1999 Oct; 17(1):128-38. PubMed ID: 10497078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of Mengo virus through genetic engineering of the 5' noncoding poly(C) tract.
    Duke GM; Osorio JE; Palmenberg AC
    Nature; 1990 Feb; 343(6257):474-6. PubMed ID: 2153940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping of monoclonal antibodies raised to recombinant Mengo 3D polymerase.
    Duque H; Palmenberg AC
    Virus Genes; 1996; 13(2):159-68. PubMed ID: 8972569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus.
    Osorio JE; Hubbard GB; Soike KF; Girard M; van der Werf S; Moulin JC; Palmenberg AC
    Vaccine; 1996 Feb; 14(2):155-61. PubMed ID: 8852413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the C-terminal amino acid residue in mengovirus RNA-dependent RNA polymerase.
    Dmitrieva TM; Alexeevski AV; Shatskaya GS; Tolskaya EA; Gmyl AP; Khitrina EV; Agol VI
    Virology; 2007 Aug; 365(1):79-91. PubMed ID: 17467026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mengo virus 3C proteinase: recombinant expression, intergenus substrate cleavage and localization in vivo.
    Hall DJ; Palmenberg AC
    Virus Genes; 1996; 13(2):99-110. PubMed ID: 8972564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encephalomyocarditis virus (EMCV) proteins 2A and 3BCD localize to nuclei and inhibit cellular mRNA transcription but not rRNA transcription.
    Aminev AG; Amineva SP; Palmenberg AC
    Virus Res; 2003 Sep; 95(1-2):59-73. PubMed ID: 12921996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leader protein of encephalomyocarditis virus binds zinc, is phosphorylated during viral infection, and affects the efficiency of genome translation.
    Dvorak CM; Hall DJ; Hill M; Riddle M; Pranter A; Dillman J; Deibel M; Palmenberg AC
    Virology; 2001 Nov; 290(2):261-71. PubMed ID: 11883190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The isolation of Mengo virus stable non-capsid polypeptides from infected L cells and preliminary characterization of an RNA polymerase activity associated with polypeptide E.
    Lund GA; Scraba DG
    J Gen Virol; 1979 Aug; 44(2):391-403. PubMed ID: 230290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplanting encephalomyocarditis virus-infected porcine islet cells reverses diabetes in recipient mice but also transmits the virus.
    Brewer L; LaRue R; Hering B; Brown C; Njenga MK
    Xenotransplantation; 2004 Mar; 11(2):160-70. PubMed ID: 14962278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential distribution of non-structural proteins of foot-and-mouth disease virus in BHK-21 cells.
    García-Briones M; Rosas MF; González-Magaldi M; Martín-Acebes MA; Sobrino F; Armas-Portela R
    Virology; 2006 Jun; 349(2):409-21. PubMed ID: 16624365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of the allergen ovomucoid by a replicating Mengo virus.
    Amineva SP; Mosser AG; Binder JJ; Aminev AG; Palmenberg AC; Gern JE
    Arch Virol; 2006 Oct; 151(10):1933-46. PubMed ID: 16732496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the replicase of encephalomyocarditis virus.
    Diskin B; Rosenberg H; Traub A
    Adv Exp Med Biol; 1974 Jun; 44(1):295-308. PubMed ID: 4366015
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
    García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
    Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.